16339123

Source:http://linkedlifedata.com/resource/pubmed/id/16339123

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001128, umls-concept:C0015780, umls-concept:C0028754, umls-concept:C0034693, umls-concept:C0948265
pubmed:issue	11
pubmed:dateCreated	2005-12-12
pubmed:abstractText	The putative selective estrogen receptor modulator (+)-Z-bisdehydrodoisynolic acid (Z-BDDA) has been found to improve cardiovascular risk in rodents. The objective of this study was to investigate the effectiveness of (+)-Z-BDDA compared with the antidiabetic drug, rosiglitazone, in treating obesity and risk factors associated with the metabolic syndrome.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9305691
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/PPAR alpha, http://linkedlifedata.com/resource/pubmed/chemical/PPAR gamma, http://linkedlifedata.com/resource/pubmed/chemical/Phenanthrenes, http://linkedlifedata.com/resource/pubmed/chemical/Selective Estrogen Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/bisdehydrodoisynolic acid, http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1071-7323
pubmed:author	pubmed-author:AdlerStuartS, pubmed-author:BanzWilliam JWJ, pubmed-author:DavisJeremyJ, pubmed-author:HenryNancyN, pubmed-author:HigginbothamD AllanDA, pubmed-author:HouYuqingY, pubmed-author:MeyersCal YCY, pubmed-author:OitkerJenniferJ, pubmed-author:PetersonRichardR, pubmed-author:SteinleJena JJJ, pubmed-author:WintersTodd ATA
pubmed:issnType	Print
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1915-24
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16339123-Animals, pubmed-meshheading:16339123-Blood Glucose, pubmed-meshheading:16339123-Body Weight, pubmed-meshheading:16339123-Cholesterol, pubmed-meshheading:16339123-Coronary Vessels, pubmed-meshheading:16339123-Diabetes Mellitus, Experimental, pubmed-meshheading:16339123-Disease Models, Animal, pubmed-meshheading:16339123-Female, pubmed-meshheading:16339123-Gene Expression, pubmed-meshheading:16339123-Hypoglycemic Agents, pubmed-meshheading:16339123-Kidney, pubmed-meshheading:16339123-Liver, pubmed-meshheading:16339123-Metabolic Syndrome X, pubmed-meshheading:16339123-Obesity, pubmed-meshheading:16339123-Organ Size, pubmed-meshheading:16339123-PPAR alpha, pubmed-meshheading:16339123-PPAR gamma, pubmed-meshheading:16339123-Phenanthrenes, pubmed-meshheading:16339123-Random Allocation, pubmed-meshheading:16339123-Rats, pubmed-meshheading:16339123-Rats, Zucker, pubmed-meshheading:16339123-Risk Factors, pubmed-meshheading:16339123-Selective Estrogen Receptor Modulators, pubmed-meshheading:16339123-Thiazolidinediones, pubmed-meshheading:16339123-Triglycerides
pubmed:year	2005
pubmed:articleTitle	(+)-Z-Bisdehydrodoisynolic acid ameliorates obesity and the metabolic syndrome in female ZDF rats.
pubmed:affiliation	Department of Animal Science, Food, and Nutrition, Southern Illinois University, Carbondale, IL 62901-4317, USA. banz@siu.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't